-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics Enters Exclusive Collaboration with QIMR Berghofer to Develop First-in-Class PD-L1 Protein Degrader for Cancer Treatment

Reuters·10/07/2025 21:18:15

Please log in to view news